Literature DB >> 22483857

Insights into the pathophysiology of the antiphospholipid syndrome provided by atomic force microscopy.

Anthony S Quinn1, Xiao-Xuan Wu, Jacob H Rand, Douglas J Taatjes.   

Abstract

The antiphospholipid syndrome (APS) is an enigmatic autoimmune disorder in which patients present with thrombosis and/or recurrent pregnancy losses together with laboratory evidence for the presence of autoantibodies in the blood that recognize proteins that bind to anionic phospholipids - the most important of which is β(2)-glycoprotein I (β(2)GPI). Earlier, we hypothesized that the clinical manifestations arise from antibody-induced disruption of a two-dimensional anticoagulant crystal shield, composed of annexin A5, present on placental trophoblast plasma membranes. Accordingly, we reasoned that a high resolution imaging technology, such as atomic force microscopy could be used to investigate such molecular interactions at high resolution in a non-fixed hydrated environment. This review will focus on the contribution of this technique to the elucidation of the mechanism of APS.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22483857      PMCID: PMC3341943          DOI: 10.1016/j.micron.2012.03.010

Source DB:  PubMed          Journal:  Micron        ISSN: 0968-4328            Impact factor:   2.251


  71 in total

1.  Phospholipid-bound beta 2-glycoprotein I induces the production of anti-phospholipid antibodies.

Authors:  R Subang; J S Levine; A S Janoff; S M Davidson; T F Taraschi; T Koike; S R Minchey; M Whiteside; M Tannenbaum; J Rauch
Journal:  J Autoimmun       Date:  2000-08       Impact factor: 7.094

Review 2.  How do antiphospholipid antibodies bind beta2-glycoprotein I?

Authors:  Ian P Giles; David A Isenberg; David S Latchman; Anisur Rahman
Journal:  Arthritis Rheum       Date:  2003-08

3.  Atomic force microscope.

Authors: 
Journal:  Phys Rev Lett       Date:  1986-03-03       Impact factor: 9.161

4.  The clonal analysis of anticardiolipin antibodies in a single patient with primary antiphospholipid syndrome reveals an extreme antibody heterogeneity.

Authors:  P Lieby; A Soley; H Levallois; B Hugel; J M Freyssinet; M Cerutti; J L Pasquali; T Martin
Journal:  Blood       Date:  2001-06-15       Impact factor: 22.113

5.  Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor.

Authors:  E Matsuura; Y Igarashi; M Fujimoto; K Ichikawa; T Suzuki; T Sumida; T Yasuda; T Koike
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

Review 6.  beta2-glycoprotein I, the playmaker of the antiphospholipid syndrome.

Authors:  H Bas de Laat; Ronald H W M Derksen; Philip G de Groot
Journal:  Clin Immunol       Date:  2004-08       Impact factor: 3.969

Review 7.  Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome.

Authors:  J H Rand; X X Wu; A S Quinn; D J Taatjes
Journal:  Lupus       Date:  2008-10       Impact factor: 2.911

8.  Phospholipid binding of annexin V: effects of calcium and membrane phosphatidylserine content.

Authors:  J F Tait; D Gibson
Journal:  Arch Biochem Biophys       Date:  1992-10       Impact factor: 4.013

9.  Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus.

Authors:  J A James; X R Kim-Howard; B F Bruner; M K Jonsson; M T McClain; M R Arbuckle; C Walker; G J Dennis; J T Merrill; J B Harley
Journal:  Lupus       Date:  2007       Impact factor: 2.911

Review 10.  Thrombosis and systemic lupus erythematosus: the Hopkins Lupus Cohort perspective.

Authors:  M Petri
Journal:  Scand J Rheumatol       Date:  1996       Impact factor: 3.641

View more
  2 in total

1.  Long-circulating XTEN864-annexin A5 fusion protein for phosphatidylserine-related therapeutic applications.

Authors:  Akvile Haeckel; Lena Ascher; Nicola Beindorff; Sonal Prasad; Karolina Garczyńska; Jing Guo; Eyk Schellenberger
Journal:  Apoptosis       Date:  2021-08-17       Impact factor: 4.677

Review 2.  Reimagining the antiphospholipid syndrome, an enigmatic thrombophilic disorder, through the looking glass of microscopic imaging.

Authors:  Jacob H Rand; Douglas J Taatjes
Journal:  Histochem Cell Biol       Date:  2018-08-18       Impact factor: 4.304

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.